ScholarLens Back to search
2004•ChemInformRequires access

Antileishmanial Activity of a New 8‐Hydroxyquinoline Derivative Designed 7‐[5′‐(3′‐Phenylisoxazolino)methyl]‐8‐hydroxyquinoline: Preliminary Study.

Zainaba Dardari, Meryem Lemrani, Abdelmejid Bahloul, Abdelfatah Sebban, Mohammed Hassar, Saïd Kitane, Mohammed Berrada, Mohammed Boudouma

Open publisher page 0 citations

Abstract

Abstract For Abstract see ChemInform Abstract in Full Text.

About this research paper

What this paper is about

Abstract For Abstract see ChemInform Abstract in Full Text.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract For Abstract see ChemInform Abstract in Full Text.

Key concepts: 8-Hydroxyquinoline, Chemistry, Derivative (finance), Combinatorial chemistry, Organic chemistry, Economics, Financial economics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Antileishmanial Activity of a New 8‐Hydroxyquinoline Derivative Designed 7‐[5′‐(3′‐Phenylisoxazolino)methyl]‐8‐hydroxyquinoline: Preliminary Study. — Research Paper | ScholarLens